Novartis AG - Company Profile
Powered by 
All the sales intelligence you need on Novartis AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Novartis AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Novartis AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View more- Top 10 Pharmaceutical Companies in Europe in 2022 by Market Capitalization
- Top 10 Big Biopharma Companies (Large Pharma & Large Biotech) in Europe in 2021 by Revenues
- Top 10 Pharma Companies in Europe in 2021 by R&D Expenditure
- Top 10 Pharmaceutical Companies in the World in 2022 by Market Capitalization
Novartis AG (Novartis) is a pharmaceutical company. Improved operational performance, established market position, and strong research and development (R&D) are the company’s major strengths, even as dependence on major customers could be a cause for concern to the company. Contracts and agreements, regulatory approvals, and strategic acquisitions provide growth avenues to the company. However, geopolitical and socio-political risks, intense competition, and stringent regulations could affect its business operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer